LIVIVO - The Search Portal for Life Sciences

zur deutschen Oberfläche wechseln
Advanced search

Search results

Result 1 - 6 of total 6

Search options

  1. Article: Retroperitoneal fibrosis as a postoperative complication following renal transplantation in cats

    Byer, Brittney J / Hardie, Robert J / McAnulty, Jonathan F

    Journal of feline medicine and surgery. 2022 Apr., v. 24, no. 4

    2022  

    Abstract: The aim of this report was to describe the clinical signs, diagnostic imaging findings, surgical management, histopathological findings, outcome and possible risk factors for cats that developed retroperitoneal fibrosis (RPF) following renal ... ...

    Abstract The aim of this report was to describe the clinical signs, diagnostic imaging findings, surgical management, histopathological findings, outcome and possible risk factors for cats that developed retroperitoneal fibrosis (RPF) following renal transplantation. Medical records of cats that underwent renal transplantation and developed clinically significant RPF between 1995 and 2019 were reviewed. Eighty-one cats underwent 83 renal transplantations. Of these 81 cats, six developed clinically significant RPF. For all six cats, renal transplantation was performed using cold organ preservation solution and ureteral papilla implantation. Immunosuppression protocol included ciclosporin and prednisolone. All cats had at least one subtherapeutic trough ciclosporin level (<250 ng/ml) in the postoperative period. Cats presented with moderate-to-severe azotemia 39–210 days following renal transplantation. Abdominal ultrasonography and contrast pyelography revealed various degrees of hydroureter and hydronephrosis of the transplanted kidney. Surgical examination revealed a layer of dense fibrous tissue surrounding the transplanted kidney, ureter and bladder resulting in ureteral obstruction. Ureteral obstruction was managed by reimplantation of the proximal ureter or renal pelvis to the bladder. Histopathologic examination of the fibrous tissue and affected portion of the distal ureter revealed fibrous connective tissue with lymphoplasmacytic infiltration and perivascular inflammation suggestive of an autoimmune type reaction. Of the six cats, two died within 5 days after revision surgery, two developed signs consistent with recurrent partial ureteral obstruction (40 and 41 days after revision), one was euthanized 6 years later for an unrelated disease and one was lost to follow-up. The incidence of RPF in this population of cats was relatively low (7%), but still represents a significant cause of morbidity and mortality. The cause of RPF remains unknown, although investigation into suboptimal immunosuppression as a potential cause for local rejection reaction is warranted.
    Keywords bladder ; cats ; cold ; cyclosporine ; fibrosis ; histopathology ; immunosuppression ; inflammation ; kidney transplant ; kidneys ; medicine ; morbidity ; mortality ; pelvis ; prednisolone ; protocols ; ultrasonography ; uremia ; ureter
    Language English
    Dates of publication 2022-04
    Size p. 304-310.
    Publishing place SAGE Publications
    Document type Article
    ZDB-ID 2049047-1
    ISSN 1532-2750 ; 1098-612X
    ISSN (online) 1532-2750
    ISSN 1098-612X
    DOI 10.1177/1098612X211018976
    Database NAL-Catalogue (AGRICOLA)

    More links

    Kategorien

  2. Article ; Online: Retroperitoneal fibrosis as a postoperative complication following renal transplantation in cats.

    Byer, Brittney J / Hardie, Robert J / McAnulty, Jonathan F

    Journal of feline medicine and surgery

    2021  Volume 24, Issue 4, Page(s) 304–310

    Abstract: Objectives: The aim of this report was to describe the clinical signs, diagnostic imaging findings, surgical management, histopathological findings, outcome and possible risk factors for cats that developed retroperitoneal fibrosis (RPF) following renal ...

    Abstract Objectives: The aim of this report was to describe the clinical signs, diagnostic imaging findings, surgical management, histopathological findings, outcome and possible risk factors for cats that developed retroperitoneal fibrosis (RPF) following renal transplantation.
    Methods: Medical records of cats that underwent renal transplantation and developed clinically significant RPF between 1995 and 2019 were reviewed.
    Results: Eighty-one cats underwent 83 renal transplantations. Of these 81 cats, six developed clinically significant RPF. For all six cats, renal transplantation was performed using cold organ preservation solution and ureteral papilla implantation. Immunosuppression protocol included ciclosporin and prednisolone. All cats had at least one subtherapeutic trough ciclosporin level (<250 ng/ml) in the postoperative period. Cats presented with moderate-to-severe azotemia 39-210 days following renal transplantation. Abdominal ultrasonography and contrast pyelography revealed various degrees of hydroureter and hydronephrosis of the transplanted kidney. Surgical examination revealed a layer of dense fibrous tissue surrounding the transplanted kidney, ureter and bladder resulting in ureteral obstruction. Ureteral obstruction was managed by reimplantation of the proximal ureter or renal pelvis to the bladder. Histopathologic examination of the fibrous tissue and affected portion of the distal ureter revealed fibrous connective tissue with lymphoplasmacytic infiltration and perivascular inflammation suggestive of an autoimmune type reaction. Of the six cats, two died within 5 days after revision surgery, two developed signs consistent with recurrent partial ureteral obstruction (40 and 41 days after revision), one was euthanized 6 years later for an unrelated disease and one was lost to follow-up.
    Conclusions and relevance: The incidence of RPF in this population of cats was relatively low (7%), but still represents a significant cause of morbidity and mortality. The cause of RPF remains unknown, although investigation into suboptimal immunosuppression as a potential cause for local rejection reaction is warranted.
    MeSH term(s) Animals ; Cat Diseases/etiology ; Cat Diseases/surgery ; Cats ; Cyclosporine ; Female ; Kidney Transplantation/adverse effects ; Kidney Transplantation/veterinary ; Male ; Postoperative Complications/veterinary ; Retroperitoneal Fibrosis/etiology ; Retroperitoneal Fibrosis/surgery ; Retroperitoneal Fibrosis/veterinary ; Ureteral Obstruction/veterinary
    Chemical Substances Cyclosporine (83HN0GTJ6D)
    Language English
    Publishing date 2021-05-21
    Publishing country England
    Document type Journal Article
    ZDB-ID 2049047-1
    ISSN 1532-2750 ; 1098-612X
    ISSN (online) 1532-2750
    ISSN 1098-612X
    DOI 10.1177/1098612X211018976
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  3. Article ; Online: Evaluation of Myogenin and MyoD1 as Immunohistochemical Markers of Canine Rhabdomyosarcoma.

    Tuohy, Joanne L / Byer, Brittney J / Royer, Suzanne / Keller, Charles / Nagai-Singer, Margaret A / Regan, Daniel P / Seguin, Bernard

    Veterinary pathology

    2021  Volume 58, Issue 3, Page(s) 516–526

    Abstract: Canine rhabdomyosarcoma (RMS) presents a diagnostic challenge due to its overlapping histologic features with other soft tissue sarcomas. The diagnosis of RMS currently relies on positive immunohistochemical (IHC) labeling for desmin; however, desmin ... ...

    Abstract Canine rhabdomyosarcoma (RMS) presents a diagnostic challenge due to its overlapping histologic features with other soft tissue sarcomas. The diagnosis of RMS currently relies on positive immunohistochemical (IHC) labeling for desmin; however, desmin expression is also observed in non-RMS tumors. Myogenin and MyoD1 are transcription factors reported to be sensitive and specific IHC markers for human RMS, but they are not widely used in veterinary oncology. The goals of this study were to develop an IHC protocol for myogenin and MyoD1, evaluate myogenin and MyoD1 labeling in canine RMS, and report clinical outcomes. Sixteen cases of possible RMS were retrospectively evaluated. A diagnosis of RMS was confirmed in 13 cases based on histological features and immunolabeling for myogenin and MyoD1, with the aid of electron microscopy in 2 cases. Desmin was negative in 3 cases of RMS. Two cases were of the sclerosing variant. The median age of dogs with RMS was 7.2 years. Anatomic tumor locations included previously reported sites such as bladder, larynx, heart, and orbit, as well as other locations typical of soft tissue sarcomas. Survival ranged from 47 to 1480 days for 5 dogs with available data. This study demonstrated that MyoD1 and myogenin should be included with desmin as part of a diagnostic IHC panel for canine RMS. Utilization of these antibodies to improve the accuracy of canine RMS diagnosis will ultimately allow for better characterization of the biological behavior and clinical outcomes of this disease, providing the groundwork for future comparative investigations in canine RMS.
    MeSH term(s) Animals ; Biomarkers, Tumor ; Diagnosis, Differential ; Dog Diseases/diagnosis ; Dogs ; MyoD Protein ; Myogenin ; Retrospective Studies ; Rhabdomyosarcoma/diagnosis ; Rhabdomyosarcoma/veterinary
    Chemical Substances Biomarkers, Tumor ; MyoD Protein ; Myogenin
    Language English
    Publishing date 2021-03-11
    Publishing country United States
    Document type Journal Article ; Research Support, N.I.H., Extramural
    ZDB-ID 188012-3
    ISSN 1544-2217 ; 0300-9858
    ISSN (online) 1544-2217
    ISSN 0300-9858
    DOI 10.1177/0300985820988146
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  4. Article ; Online: Evaluation of Myogenin and MyoD1 as Immunohistochemical Markers of Canine Rhabdomyosarcoma

    Tuohy, Joanne L. / Byer, Brittney J. / Royer, Suzanne / Keller, Charles / Nagai-Singer, Margaret A. / Regan, Daniel P. / Seguin, B.

    Veterinary Pathology. 2021 May, v. 58, no. 3 p.516-526

    2021  

    Abstract: Canine rhabdomyosarcoma (RMS) presents a diagnostic challenge due to its overlapping histologic features with other soft tissue sarcomas. The diagnosis of RMS currently relies on positive immunohistochemical (IHC) labeling for desmin; however, desmin ... ...

    Abstract Canine rhabdomyosarcoma (RMS) presents a diagnostic challenge due to its overlapping histologic features with other soft tissue sarcomas. The diagnosis of RMS currently relies on positive immunohistochemical (IHC) labeling for desmin; however, desmin expression is also observed in non-RMS tumors. Myogenin and MyoD1 are transcription factors reported to be sensitive and specific IHC markers for human RMS, but they are not widely used in veterinary oncology. The goals of this study were to develop an IHC protocol for myogenin and MyoD1, evaluate myogenin and MyoD1 labeling in canine RMS, and report clinical outcomes. Sixteen cases of possible RMS were retrospectively evaluated. A diagnosis of RMS was confirmed in 13 cases based on histological features and immunolabeling for myogenin and MyoD1, with the aid of electron microscopy in 2 cases. Desmin was negative in 3 cases of RMS. Two cases were of the sclerosing variant. The median age of dogs with RMS was 7.2 years. Anatomic tumor locations included previously reported sites such as bladder, larynx, heart, and orbit, as well as other locations typical of soft tissue sarcomas. Survival ranged from 47 to 1480 days for 5 dogs with available data. This study demonstrated that MyoD1 and myogenin should be included with desmin as part of a diagnostic IHC panel for canine RMS. Utilization of these antibodies to improve the accuracy of canine RMS diagnosis will ultimately allow for better characterization of the biological behavior and clinical outcomes of this disease, providing the groundwork for future comparative investigations in canine RMS.
    Keywords animal pathology ; bladder ; desmin ; dogs ; electron microscopy ; heart ; humans ; immunohistochemistry ; larynx ; myogenin ; neoplasms ; tissues ; rhabdomyosarcoma ; muscle ; surgical pathology
    Language English
    Dates of publication 2021-05
    Size p. 516-526.
    Publishing place SAGE Publications
    Document type Article ; Online
    Note NAL-AP-2-clean
    ZDB-ID 188012-3
    ISSN 1544-2217 ; 0300-9858
    ISSN (online) 1544-2217
    ISSN 0300-9858
    DOI 10.1177/0300985820988146
    Database NAL-Catalogue (AGRICOLA)

    More links

    Kategorien

  5. Article ; Online: Equine urinary N-acetyl-β-D-glucosaminidase assay validation and correlation with other markers of kidney injury.

    Bayless, Rosemary L / Moore, A Russell / Hassel, Diana M / Byer, Brittney J / Landolt, Gabriele A / Nout-Lomas, Yvette S

    Journal of veterinary diagnostic investigation : official publication of the American Association of Veterinary Laboratory Diagnosticians, Inc

    2019  Volume 31, Issue 5, Page(s) 688–695

    Abstract: Detection of equine acute kidney injury (AKI) is hindered by limited markers of early renal damage in horses. N-acetyl-β-D-glucosaminidase (NAG), a lysosomal enzyme in renal tubular epithelium released into urine during tubular insult, has shown promise ... ...

    Abstract Detection of equine acute kidney injury (AKI) is hindered by limited markers of early renal damage in horses. N-acetyl-β-D-glucosaminidase (NAG), a lysosomal enzyme in renal tubular epithelium released into urine during tubular insult, has shown promise for early identification of AKI in humans and other species. We validated an assay for NAG in equine urine and measured urinary NAG in 7 azotemic and 7 non-azotemic client-owned adult horses. The enzymatic NAG assay was validated using within- and between-run coefficients of variation (CVs), recovery following standard addition, and linearity of dilution. Intra- and inter-run CVs (21% and 3.2%, respectively), average recovery following standard addition (99-109%), and linearity under serial dilution (
    MeSH term(s) Acetylglucosaminidase/urine ; Acute Kidney Injury/diagnosis ; Acute Kidney Injury/urine ; Acute Kidney Injury/veterinary ; Animals ; Biomarkers/urine ; Creatinine/blood ; Female ; Horse Diseases/diagnosis ; Horse Diseases/urine ; Horses ; Humans ; Male ; Sodium/urine ; gamma-Glutamyltransferase/urine
    Chemical Substances Biomarkers ; Sodium (9NEZ333N27) ; Creatinine (AYI8EX34EU) ; gamma-Glutamyltransferase (EC 2.3.2.2) ; Acetylglucosaminidase (EC 3.2.1.52)
    Language English
    Publishing date 2019-07-26
    Publishing country United States
    Document type Journal Article ; Validation Study
    ZDB-ID 287603-6
    ISSN 1943-4936 ; 1040-6387
    ISSN (online) 1943-4936
    ISSN 1040-6387
    DOI 10.1177/1040638719867124
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  6. Article ; Online: Equine urinary N-acetyl-β-D-glucosaminidase assay validation and correlation with other markers of kidney injury

    Bayless, Rosemary L. / Moore, A Russell / Hassel, Diana M. / Byer, Brittney J. / Landolt, Gabriele A. / Nout-Lomas, Yvette S.

    Journal of Veterinary Diagnostic Investigation. 2019 Sept., v. 31, no. 5 p.688-695

    2019  

    Abstract: Detection of equine acute kidney injury (AKI) is hindered by limited markers of early renal damage in horses. N-acetyl-β-D-glucosaminidase (NAG), a lysosomal enzyme in renal tubular epithelium released into urine during tubular insult, has shown promise ... ...

    Abstract Detection of equine acute kidney injury (AKI) is hindered by limited markers of early renal damage in horses. N-acetyl-β-D-glucosaminidase (NAG), a lysosomal enzyme in renal tubular epithelium released into urine during tubular insult, has shown promise for early identification of AKI in humans and other species. We validated an assay for NAG in equine urine and measured urinary NAG in 7 azotemic and 7 non-azotemic client-owned adult horses. The enzymatic NAG assay was validated using within- and between-run coefficients of variation (CVs), recovery following standard addition, and linearity of dilution. Intra- and inter-run CVs (21% and 3.2%, respectively), average recovery following standard addition (99–109%), and linearity under serial dilution (R² = 0.997) were satisfactory. Urine NAG index was significantly correlated with urinary fractional excretion of sodium (FENₐ; ρ = 0.76, p < 0.001) and plasma creatinine (ρ = 0.74, p = 0.001). Median urine NAG indices were higher in azotemic horses (p = 0.006), in horses with increased urinary FENₐ (p = 0.006), and in horses with increased urine gamma-glutamyl transferase index (p = 0.032). Urine NAG can be measured in horses and shows positive correlation with 2 current renal biomarkers. Additional work is needed to establish normal equine reference intervals and characterize the increase of urine NAG index in horses in relation to tubular injury.
    Keywords acute kidney injury ; adults ; biomarkers ; creatinine ; epithelium ; excretion ; gamma-glutamyltransferase ; horses ; kidneys ; sodium ; urine ; N-acetyl-beta-D-glucosaminidase ; renal
    Language English
    Dates of publication 2019-09
    Size p. 688-695.
    Publishing place SAGE Publications
    Document type Article ; Online
    Note Resource is Open Access
    ZDB-ID 287603-6
    ISSN 1943-4936 ; 1040-6387
    ISSN (online) 1943-4936
    ISSN 1040-6387
    DOI 10.1177/1040638719867124
    Database NAL-Catalogue (AGRICOLA)

    More links

    Kategorien

To top